Published in Pediatrics on August 01, 2001
Maternal and neonatal herpes simplex virus infections. N Engl J Med (2009) 2.85
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Neonatal herpes simplex infection. Clin Microbiol Rev (2004) 2.06
Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics (2011) 1.63
Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol (2003) 1.53
Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J (2009) 1.51
Neonatal herpes virus infection and extracorporeal life support. Pediatr Crit Care Med (2010) 1.40
HSV-2: in pursuit of a vaccine. J Clin Invest (2011) 1.29
Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol (2016) 1.23
Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect Dis (2004) 1.19
Pathophysiology and treatment of septic shock in neonates. Clin Perinatol (2010) 1.17
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther (2009) 1.12
Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res (2009) 1.09
Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection. J Virol (2003) 1.00
Macrophages and cytokines in the early defence against herpes simplex virus. Virol J (2005) 1.00
Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG (2011) 0.99
Current status and prospects for development of an HSV vaccine. Vaccine (2013) 0.98
Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol (2011) 0.93
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93
Neonatal herpes simplex virus infection. Clin Obstet Gynecol (2012) 0.92
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics (2013) 0.91
Neonatal herpes simplex fulminant hepatitis successfully treated with acyclovir. J Clin Neonatol (2012) 0.90
The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Can J Infect Dis Med Microbiol (2007) 0.88
The use of antiviral drugs during the neonatal period. Clin Perinatol (2012) 0.86
The Type I Interferon Response Determines Differences in Choroid Plexus Susceptibility between Newborns and Adults in Herpes Simplex Virus Encephalitis. MBio (2016) 0.85
Herpes Simplex Virus in Children. Curr Treat Options Neurol (2002) 0.85
Imaging findings of neonatal herpes simplex virus type 2 encephalitis. Neuroradiology (2008) 0.84
Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis (2016) 0.84
The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Transm Infect (2002) 0.84
Prevention and management of neonatal herpes simplex virus infections. Paediatr Child Health (2014) 0.84
High prevalence of sexually transmitted infections in pregnant adolescent girls in Tanzania: a multi-community cross-sectional study. Sex Transm Infect (2015) 0.84
Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev (2010) 0.83
Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation. J Virol (2012) 0.83
Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco. BMC Infect Dis (2007) 0.82
Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults. PLoS Pathog (2015) 0.82
Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation. Eur J Pediatr (2004) 0.82
Acute liver failure in pregnancy: Challenges and management. Indian J Anaesth (2015) 0.81
Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerg Infect Dis (2007) 0.81
Frequent genital HSV-2 shedding among women during labor in Soweto, South Africa. Infect Dis Obstet Gynecol (2014) 0.81
Herpes simplex virus infection in neonates and young infants with sepsis. Iran Red Crescent Med J (2014) 0.80
Preventing herpes simplex virus in the newborn. Clin Perinatol (2014) 0.80
Whole blood polymerase chain reaction in a neonate with disseminated herpes simplex virus infection and liver failure. AJP Rep (2013) 0.80
HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain. Proc Natl Acad Sci U S A (2015) 0.80
Sexually transmitted infections among patients with herpes simplex virus at King Abdulaziz University Hospital. BMC Res Notes (2013) 0.77
Neonatal herpes simplex virus presenting with isolated liver failure. IDCases (2014) 0.77
The scarlet H. J Infect Dis (2013) 0.77
Congenital anomalies and resource utilization in neonates infected with herpes simplex virus. Sex Transm Dis (2009) 0.77
Autophagy interaction with herpes simplex virus type-1 infection. Autophagy (2016) 0.77
Herpes Simplex Virus Infections of the Newborn. Curr Treat Options Neurol (2005) 0.77
Relapse of neonatal herpes simplex virus infection. Arch Dis Child Fetal Neonatal Ed (2003) 0.77
Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain. J Clin Microbiol (2012) 0.77
Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol (2017) 0.77
Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Rev Vaccines (2014) 0.76
Comparative performance of the Uni-Gold™ HSV-2 Rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory. J Clin Virol (2014) 0.76
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV. Pediatr Res (2014) 0.76
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs. Antiviral Res (2011) 0.76
Fulminant hepatic failure in a newborn with herpes simplex virus 2 infection. Eur J Pediatr (2005) 0.75
Current management of Herpes simplex infection in pregnant women and their newborn infants: What's hot and what's not. Paediatr Child Health (2003) 0.75
Herpes simplex testing in neonates in the emergency department. Pediatr Emerg Care (2012) 0.75
Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure. Am J Case Rep (2017) 0.75
Fulminant Hepatitis Due to Father-to-Newborn Transmission of Herpes Simplex Virus type 1. Open Virol J (2013) 0.75
[Viral infections of the fetus and newborn infant]. Pediatr Med Chir (2009) 0.75
Avidity of antibodies against HSV-2 and risk to neonatal transmission among Mexican pregnant women. Infect Dis Obstet Gynecol (2013) 0.75
Herpetic neonatal pustular rash. BMJ Case Rep (2009) 0.75
Safety of High-Dose Acyclovir in Infants with Suspected and Confirmed Neonatal Herpes Simplex Virus Infections. Pediatr Infect Dis J (2016) 0.75
Electroencephalography as an Adjunct in the Diagnosis of HSV Encephalitis in Preterm Twins. Glob Pediatr Health (2015) 0.75
Mother-to-Child Transmission of Herpes Simplex Virus. J Pediatric Infect Dis Soc (2014) 0.75
Current management of Herpes simplex infection in pregnant women and their newborn infants: What's hot and what's not. Can J Infect Dis (2003) 0.75
Neonatal sepsis: A, B, C--don't ever forget herpes. BMJ Case Rep (2011) 0.75
Cutaneous neonatal herpes simplex virus infection type 2: a case report. An Bras Dermatol (2016) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med (2000) 6.90
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
Heat shock proteins of higher plants. Proc Natl Acad Sci U S A (1981) 6.59
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect Immun (1976) 4.35
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
Dissocation and reassembly of polyribosomes in relation to protein synthesis in the soybean root. J Mol Biol (1967) 4.27
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet (1990) 4.12
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med (1992) 3.91
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med (1991) 3.78
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr (1981) 3.42
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr (2003) 3.38
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother (1992) 3.31
Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract (2000) 3.13
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol (2001) 2.90
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol (1995) 2.87
RNA and protein biosynthesis and the regulation of cell elongation by auxin. Ann N Y Acad Sci (1967) 2.86
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80
Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res (2000) 2.80
Pharmacokinetics of sevoflurane uptake into the brain and body. Anaesthesia (2003) 2.78
Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg (1992) 2.72
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med (1986) 2.63
Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics (2001) 2.62
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med (1978) 2.52
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem (2000) 2.47
Conformations and interactions of pectins. II. Influences of residue sequence on chain association in calcium pectate gels. J Mol Biol (1982) 2.43
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Varicella vaccine in pregnancy. BMJ (1996) 2.38
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol (1997) 2.34
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis (1998) 2.24
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A (1998) 2.22
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Reliability of a history of previous varicella infection in adults. JAMA (1997) 2.13
Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis (1995) 2.13
Mammary tuberculosis: report on 52 cases. Postgrad Med J (2002) 2.12
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med (1976) 2.09
Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother (1995) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Resurgence of tuberculosis in children. J Pediatr (1992) 2.05
Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis (1994) 2.04
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med (1987) 1.99
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99